The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

Naomi Pode-Shakked, Rachel Shukrun, Michal Mark-Danieli, Peter Tsvetkov, Sarit Bahar, Sara Pri-Chen, Ronald S. Goldstein, Eithan Rom-Gross, Yoram Mor, Edward Fridman, Karen Meir, Amos Simon, Marcus Magister, Naftali Kaminski, Victor S. Goldmacher, Orit Harari-Steinberg, Benjamin Dekel

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

There are considerable differences in tumour biology between adult and paediatric cancers. The existence of cancer initiating cells/cancer stem cells (CIC/CSC) in paediatric solid tumours is currently unclear. Here, we show the successful propagation of primary human Wilms' tumour (WT), a common paediatric renal malignancy, in immunodeficient mice, demonstrating the presence of a population of highly proliferative CIC/CSCs capable of serial xenograft initiation. Cell sorting and limiting dilution transplantation analysis of xenograft cells identified WT CSCs that harbour a primitive undifferentiated - NCAM1 expressing - "blastema" phenotype, including a capacity to expand and differentiate into the mature renal-like cell types observed in the primary tumour. WT CSCs, which can be further enriched by aldehyde dehydrogenase activity, overexpressed renal stemness and genes linked to poor patient prognosis, showed preferential protein expression of phosphorylated PKB/Akt and strong reduction of the miR-200 family. Complete eradication of WT in multiple xenograft models was achieved with a human NCAM antibody drug conjugate. The existence of CIC/CSCs in WT provides new therapeutic targets.

Original languageEnglish
Pages (from-to)18-37
Number of pages20
JournalEMBO Molecular Medicine
Volume5
Issue number1
DOIs
StatePublished - Jan 2013

Keywords

  • Cancer initiating cells
  • Cancer stem cells
  • Kidney stem cells
  • Renal progenitor cells
  • Targeted therapy

Fingerprint

Dive into the research topics of 'The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets'. Together they form a unique fingerprint.

Cite this